AAAAAA
Results: 1-25/27
Authors:
Low, SE
Horsman, JM
Hancock, H
Walters, SJ
Hancock, BW
Citation: Se. Low et al., Prognostic markers in malignant lymphoma: An analysis of 1,198 patients treated at a single centre, INT J ONCOL, 19(6), 2001, pp. 1203-1209
Authors:
Zekri, J
Ahmed, N
Coleman, RE
Hancock, BW
Citation: J. Zekri et al., The skeletal metastatic complications of renal cell carcinoma, INT J ONCOL, 19(2), 2001, pp. 379-382
Authors:
Ching, HY
Horsman, JM
Radstone, CR
Hancock, H
Timperley, WR
Hancock, BW
Citation: Hy. Ching et al., Non-Hodgkin's lymphoma presenting with spinal involvement: the Sheffield Lymphoma Group experience (1970-2000), INT J ONCOL, 19(1), 2001, pp. 149-156
Authors:
Koh, PK
Horsman, JM
Radstone, CR
Hancock, H
Goepel, JR
Hancock, BW
Citation: Pk. Koh et al., Localised extranodal non-Hodgkin's lymphoma of the gastrointestinal tract:Sheffield Lymphoma Group experience (1989-1998), INT J ONCOL, 18(4), 2001, pp. 743-748
Authors:
Hancock, BW
Citation: Bw. Hancock, Management of patients with lymphoma: The way forward, CL ONCOL-UK, 13(4), 2001, pp. 242-242
Authors:
Burton, JL
Lidbury, EA
Gillespie, AM
Tidy, JA
Smith, O
Lawry, J
Hancock, BW
Wells, M
Citation: Jl. Burton et al., Over-diagnosis of hydatidiform mole in early tubal ectopic pregnancy, HISTOPATHOL, 38(5), 2001, pp. 409-417
Authors:
Blackhall, FH
Ranson, M
Radford, JA
Hancock, BW
Soukop, M
McGown, AT
Robbins, A
Halbert, G
Jayson, GC
Citation: Fh. Blackhall et al., A phase II trial of bryostatin 1 in patients with non-Hodgkin's lymphoma, BR J CANC, 84(4), 2001, pp. 465-469
Authors:
Hough, RE
Goepel, JR
Alcock, HE
Hancock, BW
Lorigan, PC
Hammond, DW
Citation: Re. Hough et al., Copy number gain at 12q12-14 may be important in the transformation from follicular lymphoma to diffuse large B cell lymphoma, BR J CANC, 84(4), 2001, pp. 499-503
Authors:
Hancock, BW
Gregory, WM
Cullen, MH
Hudson, GV
Burton, A
Selby, P
Maclennan, KA
Jack, A
Bessell, EM
Smith, P
Linch, DC
Citation: Bw. Hancock et al., ChlVPP alternating with PABIOE is superior to PABIOE alone in the initial treatment of advanced Hodgkin's disease: results of a British National Lymphoma Investigation/Central Lymphoma Group randomized controlled trial, BR J CANC, 84(10), 2001, pp. 1293-1300
Authors:
Hancock, BW
Welch, EM
Gillespie, AM
Newlands, ES
Citation: Bw. Hancock et al., A retrospective comparison of current and proposed staging and scoring systems for persistent gestational trophoblastic disease, INT J GYN C, 10(4), 2000, pp. 318-322
Authors:
Kohorn, EI
Goldstein, DP
Hancock, BW
Kim, SJ
Lurain, JR
Newlands, E
Soper, JT
Wong, LC
Citation: Ei. Kohorn et al., Combining the staging system of the International Federation of Gynecologyand Obstetrics with the scoring system of the World Heath Organization forTrophoblastic Neoplasia. Report of the Working Committee of the International Society for the Study of Trophoblastic Disease and the International Gynecologic Cancer Society, INT J GYN C, 10(1), 2000, pp. 84-88
Authors:
El Helw, LM
Lorigan, PC
Robinson, MH
Coleman, RE
Hancock, BW
Citation: Lm. El Helw et al., VEDex (vincristine, epirubicin dexamethasone): an effective and well tolerated palliative chemotherapy regimen for non-Hodgkin's lymphoma, INT J ONCOL, 16(4), 2000, pp. 777-782
Authors:
Linch, DC
Smith, P
Hancock, BW
Hoskin, PJ
Cunningham, DC
Newland, AC
Milligan, D
Stevenson, PA
Wood, JK
Maclennan, KA
Hudson, BV
Hudson, GV
Gregory, WM
Citation: Dc. Linch et al., A randomised British National Lymphoma Investigation trial of CHOP vs. a weekly multi-agent regimen (PACEBOM) in patients with histologically aggressive non-Hodgkin's lymphoma, ANN ONCOL, 11, 2000, pp. 87-90
Authors:
Swerdlow, AJ
Barber, JA
Hudson, GV
Cunningham, D
Gupta, RK
Hancock, BW
Horwich, A
Lister, TA
Linch, DC
Citation: Aj. Swerdlow et al., Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: The relation to age at treatment, J CL ONCOL, 18(3), 2000, pp. 498-509
Authors:
Hancock, BW
Harris, S
Wheatley, K
Gore, M
Citation: Bw. Hancock et al., Adjuvant interferon-alpha in malignant melanoma: current status, CANC TR REV, 26(2), 2000, pp. 81-89
Authors:
Lorigan, PC
Sharma, S
Bright, N
Coleman, RE
Hancock, BW
Citation: Pc. Lorigan et al., Characteristics of women with recurrent molar pregnancies, GYNECOL ONC, 78(3), 2000, pp. 288-292
Authors:
Tidy, JA
Gillespie, AM
Bright, N
Radstone, CR
Coleman, RE
Hancock, BW
Citation: Ja. Tidy et al., Gestational trophoblastic disease: A study of mode of evacuation and subsequent need for treatment with chemotherapy, GYNECOL ONC, 78(3), 2000, pp. 309-312
Authors:
Dobson, LS
Lorigan, PC
Coleman, RE
Hancock, BW
Citation: Ls. Dobson et al., Persistent gestational trophoblastic disease: results of MEA (methotrexate, etoposide and dactinomycin) as first-line chemotherapy in high risk disease and EA (etoposide and dactinomycin) as second-line therapy for low risk disease, BR J CANC, 82(9), 2000, pp. 1547-1552
Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy
Authors:
Gillespie, AM
Kumar, S
Hancock, BW
Citation: Am. Gillespie et al., Treatment of persistent trophoblastic disease later than 6 months after diagnosis of molar pregnancy, BR J CANC, 82(8), 2000, pp. 1393-1395
Authors:
Gillespie, AM
Liyim, D
Goepel, JR
Coleman, RE
Hancock, BW
Citation: Am. Gillespie et al., Placental site trophoblastic tumour: a rare but potentially curable cancer- Clinical experience at the Trophoblastic Disease Screening and TreatmentCentre, Sheffield, UK, BR J CANC, 82(6), 2000, pp. 1186-1190
Authors:
Hough, RE
Smith, CML
Nakielny, RA
Robinson, MH
Jacubowski, J
Lorigan, PC
Hancock, BW
Citation: Re. Hough et al., Primary intracerebral lymphoma: A clinicopathological study of 28 patients, INT J ONCOL, 14(4), 1999, pp. 647-652
Authors:
Karl, KA
Hancock, BW
Citation: Ka. Karl et Bw. Hancock, Expert advice on employment termination practices: How expert is it?, PUBL PERS M, 28(1), 1999, pp. 51-62
Authors:
Sharma, S
Jagdev, S
Coleman, RE
Hancock, BW
Lorigan, PC
Citation: S. Sharma et al., Serosal complications of single-agent low-dose methotrexate used in gestational trophoblastic diseases: first reported case of methotrexate-induced peritonitis, BR J CANC, 81(6), 1999, pp. 1037-1041
Authors:
Dobson, LS
Gillespie, AM
Coleman, RE
Hancock, BW
Citation: Ls. Dobson et al., The presentation and management of post-partum choriocarcinoma, BR J CANC, 79(9-10), 1999, pp. 1531-1533
Authors:
Gillespie, AM
Siddiqui, N
Coleman, RE
Hancock, BW
Citation: Am. Gillespie et al., Gestational trophoblastic disease: does central nervous system chemoprophylaxis have a role?, BR J CANC, 79(7-8), 1999, pp. 1270-1272